Arbutus Biopharma Corp ABUS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2010-11-13
Arbutus Biopharma Corp insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Nguyen Tuan | Chief Financial Officer | 2026-02-02 | Grant | 73,500 | — |
| Androski Lindsay | President and CEO | 2026-02-02 | Grant | 28,000 | — |
| Naftzger J. Christopher | General Counsel and CCO | 2025-02-14 | Grant | 54,300 | — |
Source: SEC EDGAR filings · CIK 0001447028 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.